Incannex Healthcare Limited

IXHL | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.64

+$0.05 (+1.39%)

At close: Sep 18, 2026, 4:00 PM ET

$3.58

-$0.06 (-1.56%)

Pre-market: Sep 21, 2026, 8:50 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.39%

(1D)

Rating

Updated: Aug 22, 2026

Fundamentals Weak

Market Sentiment Bullish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $43.55M

1D Range

3.45 3.71

52W Range

2.49 20.31

Valuation (TTM)

PE -1.62

PB 0.58

EV/EBITDA 0.58

Valuation (NTM)

Forward PE 32.44

Forward PEG -0.05

Price Target N/A

Cash Flow

FCF Yield -30.8%

SBC Adj. FCF Yield -43.0%

SBC Impact -39.7%

Margins

Gross Margin -192.7%

Operating Margin -42898.1%

FCF Margin -20112.3%

Growth (CAGR)

Revenue 3Y | 5Y -54.0% | -44.2%

Dil EPS 3Y | 5Y 92.7% | -1.3%

FCF 3Y | 5Y -31.9% | -46.7%

Returns

ROA -56.1%

ROE -97.0%

ROIC -35.0%

Financial Health

Net Cash

$74.45M

Current Ratio 48.27

Interest Coverage -195.31

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Incannex Healthcare Limited is an Australian company dedicated to the research, development, and commercialization of medicinal cannabinoid products. The firm offers pharmaceutical-grade cannabinoid c...

Sector Healthcare

Industry Biotechnology

Employees 12

IPO Date Mar 1, 2022

Website www.incannex.com

Fiscal Year July - June

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Sep 21, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞